130 related articles for article (PubMed ID: 9603224)
1. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies.
Gressens P; Marret S; Martin JL; Laquerrière A; Lombet A; Evrard P
J Neurochem; 1998 Jun; 70(6):2574-84. PubMed ID: 9603224
[TBL] [Abstract][Full Text] [Related]
2. VIP neuroprotection against excitotoxic lesions of the developing mouse brain.
Gressens P
Ann N Y Acad Sci; 1999; 897():109-24. PubMed ID: 10676440
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives.
Gressens P; Besse L; Robberecht P; Gozes I; Fridkin M; Evrard P
J Pharmacol Exp Ther; 1999 Mar; 288(3):1207-13. PubMed ID: 10027860
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
[TBL] [Abstract][Full Text] [Related]
5. Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity.
Gressens P; Marret S; Bodénant C; Schwendimann L; Evrard P
J Mol Neurosci; 1999; 13(1-2):199-210. PubMed ID: 10691306
[TBL] [Abstract][Full Text] [Related]
6. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
7. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge.
Husson I; Mesplès B; Bac P; Vamecq J; Evrard P; Gressens P
Ann Neurol; 2002 Jan; 51(1):82-92. PubMed ID: 11782987
[TBL] [Abstract][Full Text] [Related]
8. [Prenatal inhibition of intestinal vasoactive peptide and cerebral excitatory lesions in the newborn mouse].
Lamboley G; Evrard P; Gressens P
Arch Pediatr; 1999 Jan; 6(1):67-74. PubMed ID: 9974100
[TBL] [Abstract][Full Text] [Related]
9. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge.
Husson I; Rangon CM; Lelièvre V; Bemelmans AP; Sachs P; Mallet J; Kosofsky BE; Gressens P
Cereb Cortex; 2005 Mar; 15(3):250-61. PubMed ID: 15269108
[TBL] [Abstract][Full Text] [Related]
10. Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity.
Gressens P; Schwendimann L; Husson I; Sarkozy G; Mocaer E; Vamecq J; Spedding M
Eur J Pharmacol; 2008 Jun; 588(1):58-63. PubMed ID: 18466899
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of leptin in vivo and in vitro.
Dicou E; Attoub S; Gressens P
Neuroreport; 2001 Dec; 12(18):3947-51. PubMed ID: 11742217
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
13. Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain.
Rogido M; Husson I; Bonnier C; Lallemand MC; Mérienne C; Gregory GA; Sola A; Gressens P
Brain Res Dev Brain Res; 2003 Feb; 140(2):287-97. PubMed ID: 12586434
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression.
Degos V; Charpentier TL; Chhor V; Brissaud O; Lebon S; Schwendimann L; Bednareck N; Passemard S; Mantz J; Gressens P
Anesthesiology; 2013 May; 118(5):1123-32. PubMed ID: 23353792
[TBL] [Abstract][Full Text] [Related]
15. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.
Keller M; Simbruner G; Górna A; Urbanek M; Tinhofer I; Griesmaier E; Sarkozy G; Schwendimann L; Gressens P
Pediatr Res; 2006 Apr; 59(4 Pt 1):549-53. PubMed ID: 16549527
[TBL] [Abstract][Full Text] [Related]
16. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice.
Medja F; Lelièvre V; Fontaine RH; Lebas F; Leroux P; Ouimet T; Saria A; Rougeot C; Dournaud P; Gressens P
Brain; 2006 Dec; 129(Pt 12):3209-23. PubMed ID: 17028311
[TBL] [Abstract][Full Text] [Related]
17. Topiramate prevents excitotoxic damage in the newborn rodent brain.
Sfaello I; Baud O; Arzimanoglou A; Gressens P
Neurobiol Dis; 2005 Dec; 20(3):837-48. PubMed ID: 16009561
[TBL] [Abstract][Full Text] [Related]
18. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.
Gozes I; Perl O; Giladi E; Davidson A; Ashur-Fabian O; Rubinraut S; Fridkin M
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4143-8. PubMed ID: 10097177
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain.
Laudenbach V; Calo G; Guerrini R; Lamboley G; Benoist JF; Evrard P; Gressens P
J Clin Invest; 2001 Feb; 107(4):457-66. PubMed ID: 11181645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
